Overview

The Protective Effects of Sevoflurane in Pediatric Cardiac Surgery

Status:
Unknown status
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
During repair of a congenital heart defect the child is exposed to myocardial hypoxia. Recent studies have suggested that the paediatric myocardium is more sensitive to hypoxia and cardioplegic arrest than the adult. The protective effect of halogenated agents on ischaemia and reperfusion injury has been investigated widely in adults. The investigators hypothesis that sevoflurane applied during cardiopulmonary bypass might afford better myocardial protection during paediatric cardiac surgery.
Phase:
N/A
Details
Lead Sponsor:
Xijing Hospital
Treatments:
Sevoflurane